History
| 2025 | Fresenius Medical Care is the leading kidney care company globally with ~300,000 patients and >174m dialyzers per year. The updated 5008x CAREsystem with additional features receives FDA clearance. Launch of our new strategy FME Reignite, setting the ambition to lead kidney care through exceptional patient care and innovation. |
| 2024 | Fresenius Medical Care receives the clearance from U.S. Food and Drug Administration (FDA) for our 5008X Hemodialysis System, enabling us to offer high-volume hemodiafiltration (HVHDF) dialysis therapy in the U.S. |
| 2023 | Fresenius Medical Care announces the successful completion of its change of legal form from a partnership limited by shares into a German stock corporation. |
| 2021 | 25th anniversary as the world's leading provider of products and services for individuals with renal diseases. |
| 2020 | Launch of the Global Sustainability Program that will enable us to step up our efforts to integrate sustainability into our business over the next years. Production of the 2-billionth dialyzer – just seven years after the production of the 1-billionth. |
| 2019 | By acquiring NxStage Medical, Inc., Fresenius Medical Care expands its product portfolio with an innovative technology for home hemodialysis offering patients greater flexibility. |
| 2018 | Fresenius Medical Care launches the 4008A dialysis machine tailored to needs in emerging markets. |
| 2016 | Launch of the 6008 CAREsystem, a new hemodialysis therapy system, that delivers advanced dialysis therapy more easily, leaving more time for direct patient care. |
| 2014 | A new generation of home dialysis cyclers is launched – sleep•safe harmony – enabling most individualized treatment options with adapted APD (aAPD) therapy. |
| 2013 | Fresenius Medical Care produces the 1.000.000.000th dialyzer. |
| 2012 | Fresenius Medical Care produces the 500,000th dialysis machine. |
| 2011 | The worldwide expansion of the service business continues by acquiring IDC, Liberty Dialysis Holdings Inc. and American Access Care. |
| 2010 | Foundation of a joint venture to develop and sell drugs for patients with chronic kidney disease. |
| 2007 | Fresenius Medical Care continues its success as the leading manufacturer of dialyzers, producing its 500,000,000th dialyzer |
| 2006 | Fresenius Medical Care acquired the U.S. dialysis care provider Renal Care Group, Inc. Through its network of around 2.000 dialysis clinics around the world the company provides dialysis treatments to approximately 157,000 patients. Fresenius Medical Care also transforms its legal form into KGaA |
| 2005 | The new dialysis therapy system 5008 is introduced in the market and wins the prize “Innovationspreis der Deutschen Wirtschaft". |
| 2003 | Fresenius Medical Care is the leading dialysis company caring for more than 119,000 patients in own dialysis centers worldwide. With a production output of more than 50 million dialyzers per year the company sets a new record. |
| 1999 | The 100,000th dialysis machine comes off the production line. Fresenius Medical Cares’ ordinary share is admitted to the DAX, Germany’s blue-chip share index. |
| 1996 | Fresenius Medical Care is founded from a merger of Fresenius Worldwide Dialysis and National Medical Care. The company’s shares are listed at the stock exchanges in Frankfurt and New York. |
| 1983 | The Company takes up the production of synthetic polysulfone fiber membranes for blood purification. These membranes today set the quality standards for dialyzers. |
| 1979 | In a newly acquired factory in Schweinfurt, Germany, the production of the A2008 dialysis machine begins. The new machine was very successful, and awarded a gold medal for technological innovation at the Leipzig Trade Fair. |
| 1974 | Fresenius starts to manufacture infusion solutions and medical disposables in St. Wendel, Germany. Today. Fresenius Medical Care produces highly innovative Polysulfone dialyzers in St. Wendel. |
| 1966 | Fresenius starts to sell dialysis machines and dialyzers manufactured by various foreign companies and gains substantial market shares. |
| 1951 | Else Fernau, later Else Kröner, takes over the responsibility for the pharmacy and company after she has obtained her degree in pharmacy studies |
| 1934 | The Production unit separated from the Hirsch Pharmacy and relocated to nearby Bad Homburg. |
| 1912 | Dr. Eduard Fresenius, pharmacist and proprietor of the Hirsch Pharmacy commences the production of pharmaceuticals. |
| 1462 | Foundation of the Hirsch Pharmacy in Frankfurt am Main. The Fresenius family assumes ownership in the 18th century. |